Ionis Pharmaceuticals IONS Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options?
- Ionis Pharmaceuticals (IONS) reported proceeds from issuance of shares under incentive and share based compensation plans including stock options of $57.3M in Q1 2026.
- How has Ionis Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options changed year-over-year?
- Ionis Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options increased by 2457.0% year-over-year, from $2.24M to $57.3M.
- What is the long-term trend for Ionis Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's proceeds from issuance of shares under incentive and share based compensation plans including stock options has grown at a 102.0% compound annual growth rate (CAGR), from $11.57M to $192.6M.
- What does proceeds from issuance of shares under incentive and share based compensation plans including stock options mean?
- Cash received from employees buying company stock through incentive plans.
- How do you interpret proceeds from issuance of shares under incentive and share based compensation plans including stock options?
- Higher proceeds indicate increased employee participation in equity programs, which can be a source of non-dilutive capital.
- How does proceeds from issuance of shares under incentive and share based compensation plans including stock options compare across companies?
- Standard line item for companies with robust employee equity incentive programs.